These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6806420)

  • 1. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate.
    Acs Z; Antoni FA; Makara GB
    J Endocrinol; 1982 May; 93(2):239-45. PubMed ID: 6806420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence.
    Bloch B; Ling N; Benoit R; Wehrenberg WB; Guillemin R
    Nature; 1984 Jan 19-25; 307(5948):272-3. PubMed ID: 6420704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats.
    Corder R; Saudan P; Mazlan M; McLean C; Gaillard RC
    Neuroendocrinology; 1990 Jan; 51(1):85-92. PubMed ID: 2106092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions.
    Meister B; Ceccatelli S; Hökfelt T; Andén NE; Andén M; Theodorsson E
    Exp Brain Res; 1989; 76(2):343-68. PubMed ID: 2569986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased responsiveness of the hypothalamic-pituitary axis after neurotoxin-induced hypothalamic denervation.
    Spinedi E; Johnston C; Negro-Vilar A
    Endocrinology; 1984 Jul; 115(1):267-72. PubMed ID: 6145582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats.
    Wakabayashi I; Hatano H; Minami S; Tonegawa Y; Akira S; Sugihara H; Ling NC
    Brain Res; 1986 May; 372(2):361-5. PubMed ID: 3085872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypothalamo-infundibular growth hormone-releasing hormone (GH-RH) system of the rat.
    Merchenthaler I; Csontos C; Kallo I; Arimura A
    Brain Res; 1986 Jul; 378(2):297-302. PubMed ID: 3089538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat.
    Dolnikoff MS; Kater CE; Egami M; de Andrade IS; Marmo MR
    Neuroendocrinology; 1988 Dec; 48(6):645-9. PubMed ID: 3251163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamo-pituitary-adrenocortical axis.
    Larsen PJ; Mikkelsen JD; Jessop D; Lightman SL; Chowdrey HS
    J Endocrinol; 1994 Jun; 141(3):497-503. PubMed ID: 8071649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of naloxone and neonatal treatment with monosodium-L-glutamate on growth hormone and prolactin release induced by electrical stimulation of the medial-basal hypothalamus in rats.
    Antoni FA; Kanyicska B; Makara GB
    J Endocrinol; 1983 Mar; 96(3):427-32. PubMed ID: 6833931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal monosodium glutamate treatment alters the response of median eminence luteinizing hormone-releasing hormone nerve terminals to potassium and prostaglandin E2.
    DePaolo LV; Negro-Vilar A
    Endocrinology; 1982 Mar; 110(3):835-41. PubMed ID: 7035149
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
    Bodnar RJ; Truesdell LS; Nilaver G
    Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosterone treatment counteracts lesions induced by neonatal treatment with monosodium glutamate in the mediobasal hypothalamus of the male rat.
    Zoli M; Ferraguti F; Biagini G; Cintra A; Fuxe K; Agnati LF
    Neurosci Lett; 1991 Nov; 132(2):225-8. PubMed ID: 1686076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal treatment with monosodium-L-glutamate: differential effects on growth hormone and prolactin release induced by morphine.
    Antoni FA; Kanyicska B; Mezey E; Makara GB
    Neuroendocrinology; 1982 Oct; 35(4):231-5. PubMed ID: 7145019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the central nervous system-pituitary-adrenal axis in rats after neonatal treatment with monosodium glutamate.
    Magariños AM; Estivariz F; Morado MI; De Nicola AF
    Neuroendocrinology; 1988 Aug; 48(2):105-11. PubMed ID: 2851747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor.
    Millard WJ; Martin JB; Audet J; Sagar SM; Martin JB
    Endocrinology; 1982 Feb; 110(2):540-50. PubMed ID: 6120072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in corticotrophin releasing factor of the stalk median eminence in rats with various cuts around the medial basal hypothalamus.
    Makara GB; Stark E; Rappay G; Kárteszi M; Palkovits M
    J Endocrinol; 1979 Nov; 83(2):165-73. PubMed ID: 316445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosodium glutamate lesions in rat hypothalamus studied by immunohistochemistry for gonadotropin releasing hormone, neurotensin, tyrosine hydroxylase, and glutamic acid decarboxylase and by autoradiography for [3H] estradiol.
    Jennes L; Stumpf WE; Bissette G; Nemeroff CB
    Brain Res; 1984 Aug; 308(2):245-53. PubMed ID: 6148123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone releasing activity persists in the deafferented medial-basal hypothalamus of the rat.
    Antoni FA; Makara GB; Rappay G
    J Endocrinol; 1981 Dec; 91(3):415-25. PubMed ID: 6120201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.